📊 NEW FROM EULAR: How many patients with PsA switch from their first-line treatment in the first year? 📊 Explore
📊 NEW FROM EULAR: How many patients with PsA switch from their first-line treatment in the first year? 📊 Explore […]
📊 NEW FROM EULAR: How many patients with PsA switch from their first-line treatment in the first year? 📊 Explore […]
Glossary for Giant Cell Arteritis jjcush@gmail.com Wed, 08/13/2025 – 14:10
… Rheumatology. Although HIIT has demonstrated physical and cardiovascular benefits in general and clinical populations, concerns persist regarding …
Published in The Lancet Rheumatology, it is the first placebo-controlled study to demonstrate the potential effectiveness of a biomechanical …
RHD is characterized by permanent heart valve damage after a single or repeated bouts of acute rheumatic fever (ARF), a
Nailfold videocapillaroscopy (NVC) in Dx of systemic sclerosis – study of 258 NVCs found giant capillaries (specificity https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed,
Biologic Switching in Psoriasis jjcush@gmail.com Wed, 08/13/2025 – 12:19
The Patient Journey with Rheumatic Disease jjcush@gmail.com Wed, 08/13/2025 – 12:32
📊 NEW FROM EULAR: Real-world effectiveness of switching to a JAKi after first-line TNFi in PsA See how second-line t
Wondering what rheumatoid arthritis experts think about the future of treatment? Dr. Jack Cush moderates a special Tues https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
Hoffmann-Vold et al. … Hoffmann-Vold et al. The Lancet RheumatologyAugust 12, 2025.
Think Again! | Johns Hopkins Rheumatology. Johns Hopkins Rheumatology•407K views · 4:38 · Go to channel. What Does Lyme Disease
… Rheumatology. Central nervous system manifestations are increasingly being recognized in SSc. White-matter hyperintensities — especially the …
Introduction: Rheumatic heart disease (RHD) is a major public health concern, particularly in low- and middle-income countries.
The world of rheumatoid arthritis treatment has changed dramatically. What do the experts say about the evolution of bio https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
This article originally appeared on Rheumatology Advisor. References: Miller JB, Adler BL, Orbai A-M, et al. Estimating the incidence of
All patients were evaluated by a rheumatologist and followed for a minimum of 3 months. Early treatment was defined as
This work included 1401 SpA patients recruited from 15 specialized Egyptian rheumatology centers representing 20 major cities. The demographic and …
Publication date: Available online 12 August 2025 Source: The Lancet Rheumatology Author(s): Scott D Uhlrich, Valentina Mazzoli, Amy Silder, Andrea
Publication date: Available online 12 August 2025 Source: The Lancet Rheumatology Author(s): Anna-Maria Hoffmann-Vold, Oliver Distler, on behalf of the
Publication date: Available online 12 August 2025 Source: The Lancet Rheumatology Author(s): Chunmei Wu, Ran Wang, Yan Ye, Shuang Ye,
Publication date: Available online 12 August 2025 Source: The Lancet Rheumatology Author(s): Pradip Dashraath, Samantha Neubronner, Soon Leong Yong, Roziah
Several racial and ethnic groups were significantly underrepresented in pivotal psoriatic arthritis trials performed between 2000 and 2019, according to
Objective Systemic sclerosis (SSc) is a complicated autoimmune connective tissue disorder. Endothelial-to-mesenchymal transition (EndoMT) contributes to vasculopathy and fibrosis in
Arthritis &Rheumatology, Accepted Article.
Objective To evaluate dynamic changes in autoantibody and proteomic profiles in treatment-naïve systemic sclerosis (SSc) patients and identify biomarkers and
Gait analysis and pain measures show that subtly adjusting the angle of the foot during walking may reduce knee pain